Listed

Olema Pharmaceuticals, Inc.

OLMANasdaqCIK 1750284HealthcareFiscal year ends Dec 31

Share

Share this page

Story card, 1080 × 1920

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Operating income−$67.2m, Q2 FY2026
Net income−$63.2m, Q2 FY2026
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Research and development$m19.5Research and development, Q3 FY2023, three months to 2023-09-30$19.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-12, accession 0000950170-24-125427.Report this figure25.9Research and development, Q4 FY2023, three months to 2023-12-31$25.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-03-18, accession 0000950170-25-041204. Derived: 12-month figure less the 9-month figure.Report this figure29.9Research and development, Q1 FY2024, three months to 2024-03-31$29.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-13, accession 0000950170-25-070374.Report this figure29.1Research and development, Q2 FY2024, three months to 2024-06-30$29.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-11, accession 0000950170-25-106565.Report this figure33.2Research and development, Q3 FY2024, three months to 2024-09-30$33.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-10, accession 0001193125-25-273236.Report this figure32.3Research and development, Q4 FY2024, three months to 2024-12-31$32.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-16, accession 0001193125-26-107169. Derived: 12-month figure less the 9-month figure.Report this figure30.6Research and development, Q1 FY2025, three months to 2025-03-31$30.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-12, accession 0001193125-26-218156.Report this figure43.9Research and development, Q2 FY2025, three months to 2025-06-30$43.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-10, accession 0001193125-26-342383.Report this figure40.0Research and development, Q3 FY2025, three months to 2025-09-30$40.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-10, accession 0001193125-25-273236.Report this figure43.2Research and development, Q4 FY2025, three months to 2025-12-31$43.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-16, accession 0001193125-26-107169. Derived: 12-month figure less the 9-month figure.Report this figure49.2Research and development, Q1 FY2026, three months to 2026-03-31$49.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-12, accession 0001193125-26-218156.Report this figure57.8Research and development, Q2 FY2026, three months to 2026-06-30$57.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-10, accession 0001193125-26-342383.Report this figure
Operating income$m(23.3)Operating income, Q3 FY2023, three months to 2023-09-30−$23.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-12, accession 0000950170-24-125427.Report this figure(30.4)Operating income, Q4 FY2023, three months to 2023-12-31−$30.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-18, accession 0000950170-25-041204. Derived: 12-month figure less the 9-month figure.Report this figure(34.3)Operating income, Q1 FY2024, three months to 2024-03-31−$34.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-13, accession 0000950170-25-070374.Report this figure(33.5)Operating income, Q2 FY2024, three months to 2024-06-30−$33.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-11, accession 0000950170-25-106565.Report this figure(37.6)Operating income, Q3 FY2024, three months to 2024-09-30−$37.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-10, accession 0001193125-25-273236.Report this figure(36.8)Operating income, Q4 FY2024, three months to 2024-12-31−$36.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-16, accession 0001193125-26-107169. Derived: 12-month figure less the 9-month figure.Report this figure(34.9)Operating income, Q1 FY2025, three months to 2025-03-31−$34.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-12, accession 0001193125-26-218156.Report this figure(47.9)Operating income, Q2 FY2025, three months to 2025-06-30−$47.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-10, accession 0001193125-26-342383.Report this figure(45.9)Operating income, Q3 FY2025, three months to 2025-09-30−$45.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-10, accession 0001193125-25-273236.Report this figure(50.1)Operating income, Q4 FY2025, three months to 2025-12-31−$50.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-16, accession 0001193125-26-107169. Derived: 12-month figure less the 9-month figure.Report this figure(58.0)Operating income, Q1 FY2026, three months to 2026-03-31−$58.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-12, accession 0001193125-26-218156.Report this figure(67.2)Operating income, Q2 FY2026, three months to 2026-06-30−$67.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-10, accession 0001193125-26-342383.Report this figure
Interest expense$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Net income$m(21.5)Net income, Q3 FY2023, three months to 2023-09-30−$21.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-12, accession 0000950170-24-125427.Report this figure(26.8)Net income, Q4 FY2023, three months to 2023-12-31−$26.8m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-18, accession 0000950170-25-041204. Derived: 12-month figure less the 9-month figure.Report this figure(31.0)Net income, Q1 FY2024, three months to 2024-03-31−$31.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-05-13, accession 0000950170-25-070374.Report this figure(30.4)Net income, Q2 FY2024, three months to 2024-06-30−$30.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-08-11, accession 0000950170-25-106565.Report this figure(34.6)Net income, Q3 FY2024, three months to 2024-09-30−$34.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-10, accession 0001193125-25-273236.Report this figure(33.6)Net income, Q4 FY2024, three months to 2024-12-31−$33.6m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-16, accession 0001193125-26-107169. Derived: 12-month figure less the 9-month figure.Report this figure(30.4)Net income, Q1 FY2025, three months to 2025-03-31−$30.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-12, accession 0001193125-26-218156.Report this figure(43.8)Net income, Q2 FY2025, three months to 2025-06-30−$43.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-10, accession 0001193125-26-342383.Report this figure(42.2)Net income, Q3 FY2025, three months to 2025-09-30−$42.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-10, accession 0001193125-25-273236.Report this figure(46.1)Net income, Q4 FY2025, three months to 2025-12-31−$46.1m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-16, accession 0001193125-26-107169. Derived: 12-month figure less the 9-month figure.Report this figure(53.1)Net income, Q1 FY2026, three months to 2026-03-31−$53.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-12, accession 0001193125-26-218156.Report this figure(63.2)Net income, Q2 FY2026, three months to 2026-06-30−$63.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-10, accession 0001193125-26-342383.Report this figure
Diluted EPS$ per share(0.48)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$0.48 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-12, accession 0000950170-24-125427.Report this figurenot reported(0.56)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$0.56 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-13, accession 0000950170-25-070374.Report this figure(0.54)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$0.54 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-11, accession 0000950170-25-106565.Report this figure(0.60)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$0.60 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-10, accession 0001193125-25-273236.Report this figurenot reported(0.36)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$0.36 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-12, accession 0001193125-26-218156.Report this figure(0.51)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$0.51 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-10, accession 0001193125-26-342383.Report this figure(0.49)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.49 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-10, accession 0001193125-25-273236.Report this figurenot reported(0.52)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.52 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-12, accession 0001193125-26-218156.Report this figure(0.61)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.61 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-10, accession 0001193125-26-342383.Report this figure
Basic EPS$ per share(0.48)Basic EPS, Q3 FY2023, three months to 2023-09-30−$0.48 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-12, accession 0000950170-24-125427.Report this figurenot reported(0.56)Basic EPS, Q1 FY2024, three months to 2024-03-31−$0.56 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-13, accession 0000950170-25-070374.Report this figure(0.54)Basic EPS, Q2 FY2024, three months to 2024-06-30−$0.54 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-11, accession 0000950170-25-106565.Report this figure(0.60)Basic EPS, Q3 FY2024, three months to 2024-09-30−$0.60 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-10, accession 0001193125-25-273236.Report this figurenot reported(0.36)Basic EPS, Q1 FY2025, three months to 2025-03-31−$0.36 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-12, accession 0001193125-26-218156.Report this figure(0.51)Basic EPS, Q2 FY2025, three months to 2025-06-30−$0.51 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-10, accession 0001193125-26-342383.Report this figure(0.49)Basic EPS, Q3 FY2025, three months to 2025-09-30−$0.49 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-10, accession 0001193125-25-273236.Report this figurenot reported(0.52)Basic EPS, Q1 FY2026, three months to 2026-03-31−$0.52 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-12, accession 0001193125-26-218156.Report this figure(0.61)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.61 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-10, accession 0001193125-26-342383.Report this figure

Balance sheet

Cash and equivalents$48.6m, Q2 FY2026
Shareholders' equity$430.6m, Q2 FY2026
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m117Cash and equivalents, Q3 FY2023, at 2023-09-30$117.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2023-11-07, accession 0001558370-23-017994.Report this figure68.5Cash and equivalents, FY2023, at 2023-12-31$68.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-03-18, accession 0000950170-25-041204.Report this figure33.7Cash and equivalents, Q1 FY2024, at 2024-03-31$33.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-05-08, accession 0000950170-24-055686.Report this figure16.9Cash and equivalents, Q2 FY2024, at 2024-06-30$16.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-08-06, accession 0000950170-24-091836.Report this figure35.9Cash and equivalents, Q3 FY2024, at 2024-09-30$35.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-12, accession 0000950170-24-125427.Report this figure139Cash and equivalents, FY2024, at 2024-12-31$139.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-16, accession 0001193125-26-107169.Report this figure50.6Cash and equivalents, Q1 FY2025, at 2025-03-31$50.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-13, accession 0000950170-25-070374.Report this figure52.5Cash and equivalents, Q2 FY2025, at 2025-06-30$52.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-11, accession 0000950170-25-106565.Report this figure35.3Cash and equivalents, Q3 FY2025, at 2025-09-30$35.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-10, accession 0001193125-25-273236.Report this figure48.3Cash and equivalents, FY2025, at 2025-12-31$48.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-10, accession 0001193125-26-342383.Report this figure52.5Cash and equivalents, Q1 FY2026, at 2026-03-31$52.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-12, accession 0001193125-26-218156.Report this figure48.6Cash and equivalents, Q2 FY2026, at 2026-06-30$48.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-10, accession 0001193125-26-342383.Report this figure
Current assets$m282Current assets, Q3 FY2023, at 2023-09-30$282.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-07, accession 0001558370-23-017994.Report this figure267Current assets, FY2023, at 2023-12-31$266.5m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-18, accession 0000950170-25-041204.Report this figure252Current assets, Q1 FY2024, at 2024-03-31$252.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-08, accession 0000950170-24-055686.Report this figure242Current assets, Q2 FY2024, at 2024-06-30$242.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-06, accession 0000950170-24-091836.Report this figure218Current assets, Q3 FY2024, at 2024-09-30$218.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-12, accession 0000950170-24-125427.Report this figure438Current assets, FY2024, at 2024-12-31$438.5m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-16, accession 0001193125-26-107169.Report this figure397Current assets, Q1 FY2025, at 2025-03-31$396.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-13, accession 0000950170-25-070374.Report this figure368Current assets, Q2 FY2025, at 2025-06-30$367.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-11, accession 0000950170-25-106565.Report this figure334Current assets, Q3 FY2025, at 2025-09-30$334.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-10, accession 0001193125-25-273236.Report this figure515Current assets, FY2025, at 2025-12-31$515.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-10, accession 0001193125-26-342383.Report this figure513Current assets, Q1 FY2026, at 2026-03-31$513.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-12, accession 0001193125-26-218156.Report this figure470Current assets, Q2 FY2026, at 2026-06-30$469.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-10, accession 0001193125-26-342383.Report this figure
Total assets$m293Total assets, Q3 FY2023, at 2023-09-30$292.8m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-07, accession 0001558370-23-017994.Report this figure277Total assets, FY2023, at 2023-12-31$276.9m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-18, accession 0000950170-25-041204.Report this figure264Total assets, Q1 FY2024, at 2024-03-31$263.7m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-08, accession 0000950170-24-055686.Report this figure255Total assets, Q2 FY2024, at 2024-06-30$254.6m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-06, accession 0000950170-24-091836.Report this figure230Total assets, Q3 FY2024, at 2024-09-30$230.2m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-12, accession 0000950170-24-125427.Report this figure451Total assets, FY2024, at 2024-12-31$451.0m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-16, accession 0001193125-26-107169.Report this figure410Total assets, Q1 FY2025, at 2025-03-31$409.6m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-13, accession 0000950170-25-070374.Report this figure382Total assets, Q2 FY2025, at 2025-06-30$382.0m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-11, accession 0000950170-25-106565.Report this figure352Total assets, Q3 FY2025, at 2025-09-30$352.5m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-10, accession 0001193125-25-273236.Report this figure533Total assets, FY2025, at 2025-12-31$533.4m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-10, accession 0001193125-26-342383.Report this figure531Total assets, Q1 FY2026, at 2026-03-31$530.6m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-12, accession 0001193125-26-218156.Report this figure487Total assets, Q2 FY2026, at 2026-06-30$486.6m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-10, accession 0001193125-26-342383.Report this figure
Current liabilities$m16.0Current liabilities, Q3 FY2023, at 2023-09-30$16.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-07, accession 0001558370-23-017994.Report this figure21.6Current liabilities, FY2023, at 2023-12-31$21.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-18, accession 0000950170-25-041204.Report this figure26.2Current liabilities, Q1 FY2024, at 2024-03-31$26.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-08, accession 0000950170-24-055686.Report this figure26.5Current liabilities, Q2 FY2024, at 2024-06-30$26.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-06, accession 0000950170-24-091836.Report this figure30.7Current liabilities, Q3 FY2024, at 2024-09-30$30.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-12, accession 0000950170-24-125427.Report this figure41.8Current liabilities, FY2024, at 2024-12-31$41.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-16, accession 0001193125-26-107169.Report this figure26.1Current liabilities, Q1 FY2025, at 2025-03-31$26.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-13, accession 0000950170-25-070374.Report this figure33.2Current liabilities, Q2 FY2025, at 2025-06-30$33.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-11, accession 0000950170-25-106565.Report this figure41.7Current liabilities, Q3 FY2025, at 2025-09-30$41.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-10, accession 0001193125-25-273236.Report this figure51.8Current liabilities, FY2025, at 2025-12-31$51.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-10, accession 0001193125-26-342383.Report this figure47.2Current liabilities, Q1 FY2026, at 2026-03-31$47.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-12, accession 0001193125-26-218156.Report this figure53.0Current liabilities, Q2 FY2026, at 2026-06-30$53.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-10, accession 0001193125-26-342383.Report this figure
Total liabilities$m17.7Total liabilities, Q3 FY2023, at 2023-09-30$17.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-07, accession 0001558370-23-017994.Report this figure23.1Total liabilities, FY2023, at 2023-12-31$23.1m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-18, accession 0000950170-25-041204.Report this figure27.4Total liabilities, Q1 FY2024, at 2024-03-31$27.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-08, accession 0000950170-24-055686.Report this figure27.4Total liabilities, Q2 FY2024, at 2024-06-30$27.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-06, accession 0000950170-24-091836.Report this figure31.3Total liabilities, Q3 FY2024, at 2024-09-30$31.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-12, accession 0000950170-24-125427.Report this figure42.0Total liabilities, FY2024, at 2024-12-31$42.0m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-16, accession 0001193125-26-107169.Report this figure26.2Total liabilities, Q1 FY2025, at 2025-03-31$26.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-13, accession 0000950170-25-070374.Report this figure36.8Total liabilities, Q2 FY2025, at 2025-06-30$36.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-11, accession 0000950170-25-106565.Report this figure45.0Total liabilities, Q3 FY2025, at 2025-09-30$45.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-10, accession 0001193125-25-273236.Report this figure54.9Total liabilities, FY2025, at 2025-12-31$54.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-10, accession 0001193125-26-342383.Report this figure50.2Total liabilities, Q1 FY2026, at 2026-03-31$50.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-12, accession 0001193125-26-218156.Report this figure56.0Total liabilities, Q2 FY2026, at 2026-06-30$56.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-10, accession 0001193125-26-342383.Report this figure
Shareholders' equity$m275Shareholders' equity, Q3 FY2023, at 2023-09-30$275.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-12, accession 0000950170-24-125427.Report this figure254Shareholders' equity, FY2023, at 2023-12-31$253.9m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-16, accession 0001193125-26-107169.Report this figure236Shareholders' equity, Q1 FY2024, at 2024-03-31$236.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-08-11, accession 0000950170-25-106565.Report this figure227Shareholders' equity, Q2 FY2024, at 2024-06-30$227.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-10, accession 0001193125-25-273236.Report this figure199Shareholders' equity, Q3 FY2024, at 2024-09-30$198.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-10, accession 0001193125-25-273236.Report this figure409Shareholders' equity, FY2024, at 2024-12-31$409.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-10, accession 0001193125-26-342383.Report this figure383Shareholders' equity, Q1 FY2025, at 2025-03-31$383.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-10, accession 0001193125-26-342383.Report this figure345Shareholders' equity, Q2 FY2025, at 2025-06-30$345.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-10, accession 0001193125-26-342383.Report this figure307Shareholders' equity, Q3 FY2025, at 2025-09-30$307.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-10, accession 0001193125-25-273236.Report this figure479Shareholders' equity, FY2025, at 2025-12-31$478.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-10, accession 0001193125-26-342383.Report this figure480Shareholders' equity, Q1 FY2026, at 2026-03-31$480.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-10, accession 0001193125-26-342383.Report this figure431Shareholders' equity, Q2 FY2026, at 2026-06-30$430.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-10, accession 0001193125-26-342383.Report this figure

Cash flow

Operating cash flow−$45.9m, Q2 FY2026
Capital expenditure$0, Q3 FY2025
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m(22.7)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$22.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-12, accession 0000950170-24-125427. Derived: 9-month figure less the 6-month figure.Report this figure(18.5)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$18.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-03-18, accession 0000950170-25-041204. Derived: 12-month figure less the 9-month figure.Report this figure(23.5)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$23.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-13, accession 0000950170-25-070374.Report this figure(27.6)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$27.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-11, accession 0000950170-25-106565. Derived: 6-month figure less the 3-month figure.Report this figure(27.0)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$27.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-10, accession 0001193125-25-273236. Derived: 9-month figure less the 6-month figure.Report this figure(26.3)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$26.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-16, accession 0001193125-26-107169. Derived: 12-month figure less the 9-month figure.Report this figure(44.0)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$44.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-12, accession 0001193125-26-218156.Report this figure(29.9)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$29.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-10, accession 0001193125-26-342383. Derived: 6-month figure less the 3-month figure.Report this figure(34.5)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$34.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-10, accession 0001193125-25-273236. Derived: 9-month figure less the 6-month figure.Report this figure(38.3)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$38.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-16, accession 0001193125-26-107169. Derived: 12-month figure less the 9-month figure.Report this figure(46.0)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$46.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-12, accession 0001193125-26-218156.Report this figure(45.9)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$45.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-10, accession 0001193125-26-342383. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$mnot reportednot reported0.2Capital expenditure, Q1 FY2024, three months to 2024-03-31$153.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-13, accession 0000950170-25-070374.Report this figure0.0Capital expenditure, Q2 FY2024, three months to 2024-06-30$6.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-11, accession 0000950170-25-106565. Derived: 6-month figure less the 3-month figure.Report this figure0.0Capital expenditure, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-10, accession 0001193125-25-273236. Derived: 9-month figure less the 6-month figure.Report this figure0.0Capital expenditure, Q4 FY2024, three months to 2024-12-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-16, accession 0001193125-26-107169. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reported0.0Capital expenditure, Q3 FY2025, three months to 2025-09-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-10, accession 0001193125-25-273236. Derived: 9-month figure less the 6-month figure.Report this figurenot reportednot reportednot reported

Shares

Diluted shares (weighted)104.45m, Q2 FY2026
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares40.0Diluted shares (weighted), Q3 FY2022, three months to 2022-09-3040,036,201 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-07, accession 0001558370-23-017994.Report this figure40.4Diluted shares (weighted), Q1 FY2023, three months to 2023-03-3140,354,493 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-08, accession 0000950170-24-055686.Report this figure40.7Diluted shares (weighted), Q2 FY2023, three months to 2023-06-3040,720,294 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-06, accession 0000950170-24-091836.Report this figure45.0Diluted shares (weighted), Q3 FY2023, three months to 2023-09-3044,977,161 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-12, accession 0000950170-24-125427.Report this figure55.6Diluted shares (weighted), Q1 FY2024, three months to 2024-03-3155,574,324 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-13, accession 0000950170-25-070374.Report this figure56.3Diluted shares (weighted), Q2 FY2024, three months to 2024-06-3056,282,402 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-11, accession 0000950170-25-106565.Report this figure57.3Diluted shares (weighted), Q3 FY2024, three months to 2024-09-3057,262,803 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-10, accession 0001193125-25-273236.Report this figure85.4Diluted shares (weighted), Q1 FY2025, three months to 2025-03-3185,426,223 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-12, accession 0001193125-26-218156.Report this figure85.5Diluted shares (weighted), Q2 FY2025, three months to 2025-06-3085,497,426 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-10, accession 0001193125-26-342383.Report this figure85.7Diluted shares (weighted), Q3 FY2025, three months to 2025-09-3085,732,221 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-10, accession 0001193125-25-273236.Report this figure103Diluted shares (weighted), Q1 FY2026, three months to 2026-03-31102,800,098 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-12, accession 0001193125-26-218156.Report this figure104Diluted shares (weighted), Q2 FY2026, three months to 2026-06-30104,453,732 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-10, accession 0001193125-26-342383.Report this figure

Shares outstanding: 87.50mShares outstanding, period not labelled, at 2026-08-0687,497,607 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-10, accession 0001193125-26-342383.Report this figure at Aug 6, 2026, from the cover of the 10-Q filed Aug 10, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:47 ET. Listed shows no prices and gives no investment advice.